Announcements Trials
Browse Landscape

Phase

Phase 2 119Phase 1 51Phase 3 45Phase 1/2 30Phase NA 14Phase EARLY_PHASE1 3Phase 4 2

Status

Recruiting 28Unknown 25Not yet recruiting 13Completed 8Terminated 5Withdrawn 3Active not recruiting 3Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Prostatic Neoplasms 10Glioma 9Glioblastoma 8Sarcoma 7Pancreatic Neoplasms 6Neoplasms 6Neoplasm Metastasis 6Brain Neoplasms 5Recurrence 4Neuroendocrine Tumors 4Neuroblastoma 4Lymphoma 4Lung Neoplasms 4Head and Neck Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Melanoma 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Smoldering Multiple Myeloma 2Smoking Cessation 2Smoking 2Skin Neoplasms 2Sarcoma, Alveolar Soft Part 2

Interventions

iberdomide 1elotuzumab 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Active not recruiting × Multiple Myeloma × Clear all
NCT05560399 2026-01-02

CC-220

Icahn School of Medicine at Mount Sinai

Phase EARLY_PHASE1 Active not recruiting
7 enrolled
Plasma cell

Multiple Myeloma

NCT05838131 2025-01-07

Study of CT071 Injection in RRMM or PPCL

Shanghai Changzheng Hospital

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Plasma cell

Multiple Myeloma

NCT05302648 2025-01-03

To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM

Hrain Biotechnology Co., Ltd.

Phase EARLY_PHASE1 Active not recruiting
18 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡